Yes, sickle cell disease is one of the strongest risk factors for stroke, especially in children. About 11% of people with sickle cell anemia have a stroke with visible symptoms before age 20, and up to 35% of children develop “silent” strokes that cause no obvious symptoms but still damage the brain. The risk doesn’t go away in adulthood. It actually climbs sharply with age.
How Sickle Cell Disease Causes Strokes
Sickle cell disease changes the shape and behavior of red blood cells. A mutation in the hemoglobin gene produces an abnormal protein that causes red blood cells to become rigid and curved into a crescent or sickle shape under low-oxygen conditions. These stiff, misshapen cells get stuck in small blood vessels, blocking blood flow. When that blockage happens in the brain, the surrounding tissue loses oxygen and a stroke occurs.
But the blockage itself is only part of the problem. Sickled red blood cells are also unusually sticky, clinging to the walls of blood vessels and making the blood thicker and slower moving. This raises the risk of clots forming, which can block larger vessels. At the same time, sickled cells break apart much faster than healthy red blood cells. That constant destruction releases debris into the bloodstream, triggering inflammation that damages and weakens vessel walls over time.
The disease also causes the inner lining of arteries to thicken through a process called intimal hyperplasia. Smooth muscle cells in artery walls multiply, narrowing the vessels and further restricting blood flow. On top of that, the lining of blood vessels loses its ability to produce nitric oxide, a molecule that normally keeps vessels relaxed and open. The combined effect is a vascular system that is inflamed, narrowed, prone to clotting, and vulnerable to rupture.
Ischemic vs. Hemorrhagic Strokes
Sickle cell disease causes both major types of stroke, though the balance shifts with age. Ischemic strokes, caused by a blocked blood vessel, are more common overall and dominate in childhood. In a large study of nearly 70,000 sickle cell hospitalizations over a decade, ischemic strokes accounted for about two-thirds of all acute strokes, while hemorrhagic strokes (caused by a burst blood vessel) made up the remaining third in adults.
Children and young adults face similar stroke rates, roughly 310 to 360 per 100,000 person-years. But in adults aged 35 to 64, the overall rate jumps to 1,160 per 100,000 person-years. For those 65 and older, it reaches 4,700 per 100,000 person-years. Hemorrhagic strokes become a bigger concern with age, peaking in middle-aged and older adults as years of vessel wall damage take their toll. Additional risk factors like high blood pressure, kidney disease, and abnormal cholesterol levels further raise the odds.
Silent Strokes in Children
Not all strokes in sickle cell disease are obvious. Silent cerebral infarcts are small areas of brain damage that don’t produce the dramatic symptoms of a typical stroke, like arm weakness or slurred speech. A child with a silent stroke might seem fine outwardly, but imaging reveals damaged brain tissue. Up to 35% of children with the most common and severe form of sickle cell disease (HbSS) develop at least one silent infarct by age 15, and the prevalence increases steadily as they get older. Children with a milder genotype (HbSC) have lower but still notable rates, between roughly 6% and 14%.
These silent strokes are not harmless. They are linked to lower IQ scores and can affect academic performance, attention, and processing speed. They also increase the risk of having a full, symptomatic stroke later. Because they produce no obvious warning signs, they can only be detected through brain imaging, which is why screening is so important.
Warning Signs to Recognize
The symptoms of a stroke in someone with sickle cell disease are the same as in anyone else, but they can appear in very young children, which makes awareness critical for parents and caregivers. Watch for:
- One-sided weakness or paralysis in the face, arm, or leg
- Sudden confusion or difficulty speaking
- Trouble walking or loss of coordination
- Vision changes in one or both eyes
- Unexplained numbness anywhere in the body
- Severe headache with no known cause
- Seizures or loss of consciousness
Any of these symptoms in a person with sickle cell disease requires immediate emergency care. Stroke treatment is time-sensitive, and delays in reaching a hospital directly affect outcomes.
How Screening Helps Catch Risk Early
A noninvasive ultrasound test called transcranial Doppler (TCD) can measure how fast blood is moving through the arteries that supply the brain. In children with sickle cell disease, abnormally high blood flow velocities signal that vessels are narrowed and stroke risk is elevated. A velocity of 200 cm/s or higher on TCD indicates a roughly 10% chance of stroke within the following year. Velocities between 170 and 200 cm/s are considered borderline and require more frequent monitoring.
Guidelines recommend TCD screening for children with sickle cell anemia starting at age 2, with annual follow-ups. This screening program has been one of the biggest success stories in sickle cell care, identifying high-risk children early enough to intervene before a stroke happens.
Prevention Through Transfusion and Medication
For children identified as high risk through TCD screening, regular blood transfusions are the standard preventive treatment. The goal is to keep the percentage of sickle hemoglobin (HbS) below 30% to 40%, which dilutes the abnormal cells with healthy donor red blood cells and reduces the chance of vessel blockage. Randomized controlled trials have shown this approach is effective for both preventing a first stroke (primary prevention) and reducing the chance of a second stroke (secondary prevention).
Transfusions do come with long-term challenges, including iron overload from repeated treatments and the need for regular hospital visits, sometimes monthly and indefinitely. In settings where chronic transfusion isn’t practical, hydroxyurea has emerged as an alternative. This oral medication works by boosting the production of fetal hemoglobin, a form that doesn’t sickle, and has been shown to lower TCD velocities and reduce stroke risk. It’s particularly valuable in resource-limited settings where regular transfusion programs are harder to sustain.
When someone with sickle cell disease does have an acute ischemic stroke, emergency treatment typically involves an exchange transfusion, which rapidly replaces a large portion of the patient’s sickled blood with healthy donor blood, targeting a hemoglobin level of 10 g/dL and an HbS percentage below 30%.
Why Stroke Risk Rises in Adulthood
There’s a common misconception that stroke risk in sickle cell disease is mainly a childhood problem. While children are indeed at high risk and receive the most screening attention, adults face an even greater burden. The stroke rate in adults aged 35 to 64 is more than three times higher than in children, and it continues climbing in older age groups. Years of vessel damage, chronic anemia, and the development of additional conditions like high blood pressure and kidney disease compound the risk.
About a third of strokes in hospitalized adults with sickle cell disease are hemorrhagic, meaning a weakened blood vessel ruptures and bleeds into the brain. These hemorrhagic strokes carry higher mortality rates than ischemic strokes and become increasingly common in middle age. Hypertension and kidney disease are significant contributors to both stroke types in adults, making management of these conditions an important part of long-term care.